在肥胖糖尿病患者的右心房组织中,线粒体呼吸和过氧化生产率
Toan Pham1, Sarbjot Kaur2, Anthony Hickey3
1Auckland Bioengineering Institute, Auckland, New Zealand.
Experimental physiology
|February 22, 2026
概括
2型糖尿病 (T2D) 心脏表现出正常的能量生产,但氧化应激标志物减少. 这表明,当其他条件存在时,T2D可能不会显著损害人类心脏线粒体功能.
科学领域:
- 心脏病学 心脏病学
- 代谢障碍 代谢障碍 代谢障碍
- 线粒体生物学 线粒体生物学
背景情况:
- 2型糖尿病 (T2D) 是与心力衰竭相关的全球健康危机.
- 线粒体功能障碍与T2D心脏问题有关,但人类数据很少.
- 在T2D中,心脏收缩功能受损是一个主要问题.
研究的目的:
- 为了研究2型糖尿病患者的人类心脏中的线粒体功能.
- 评估T2D心脏组织中的氧化应激和能量代谢.
- 为了确定T2D对人类心脏线粒体的直接影响.
主要方法:
- 在右心房组织上使用高分辨率呼吸计和计.
- 从T2D和非糖尿病患者的透气化心脏纤维进行比较.
- 在ATP支持的条件下评估线粒体氧气 (O2) 流和过氧化 (H2O2) 生产.
主要成果:
- 在氧化酸化或ATP刺激呼吸过程中,O2流量在两组之间没有显著差异.
- 在不泄漏状态下,T2D纤维的H2O2产量较低 (每组织质量和消耗的O2).
- 在氧化酸化状态下,H2O2生产没有群体差异.
结论:
- 2型糖尿病并没有显著影响人类心脏组织中的线粒体呼吸.
- 在T2D心脏中观察到氧化应激 (H2O2产生) 的减少.
- T2D对人类心脏线粒体功能障碍的贡献可能是有限的,特别是在冠状动脉疾病和肥胖等并发症时.
相关概念视频
Imbalances in Cardiac Output
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
Mitral Regurgitation I: Introduction
Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Mitral Stenosis I: Introduction
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Diabetic Ketoacidosis ll: Pathophysiology
Diabetic ketoacidosis (DKA) is a metabolic emergency characterized by hyperglycemia, ketonemia, and metabolic acidosis. It results from severe insulin deficiency and an excess of counterregulatory hormones, leading to uncontrolled lipolysis, ketogenesis, and widespread electrolyte and fluid disturbances.Pathophysiology The central event in DKA is a profound loss of insulin action. Without insulin, glucose uptake in insulin-dependent tissues is impaired, while hepatic glucose production...


